HomeNews

News

Drug Development

FDA lifts ban on LogicBio’s clinical trial on pediatric patients with methylmalonic acidemia

Pharma -
LogicBio Therapeutics, Inc., a clinical-stage company advancing a diversified pipeline of genetic medicines addressing rare disorders from infancy through adulthood, May 9th announced that...
AI in Pharma

AbbVie and Cerebras collaborate to accelerate artificial intelligence biopharmaceutical research

Pharma -
Cerebras Systems, the pioneer in high performance artificial intelligence (AI) computing, and AbbVie, a global biopharmaceutical company, announced a landmark achievement in AbbVie’s AI...
Global Markets

Takeda Pharmaceutical expected fourth-quarter net income to decline

Pharma -
Takeda is expected to post a 92% drop in net profit from a year earlier to 15.96 billion yen ($122.3 million) for the quarter...
Regulatory

Lupin receives two FDA approvals and share price jumps

Pharma -
Global pharma major Lupin Ltd, May 06th, announced that it has received approval from the United States Food and Drug Administration (FDA) for its...
Global Markets

Clovis Oncology shares plummeted this week

Pharma -
Following the release of its first-quarter results and operational update, Clovis Oncology's shares traded down sharply. According to data provided by S&P Global Market...
Global Markets

Biogen invests $120 million in MedRhythms, a music therapy for multiple sclerosis

Pharma -
Biogen Inc. and MedRhythms have entered into a license agreement to develop and commercialize MR-004, an investigational prescription digital therapeutic for the potential treatment...
1...535455...141Page 54 of 141
spot_img

Expert Articles

spot_img